Some solar module manufacturers in India are now quoting eight-month lead times for a component that used to arrive in weeks. The bottleneck isn’t glass, isn’t EVA film, isn’t aluminium frame — it’s the solar cell itself. And it’s a structural problem that procurement teams need to plan around for the next several years, not a temporary blip.

Quick Answer

India’s solar module manufacturing capacity has scaled to roughly 200 GW, but domestic solar cell manufacturing capacity sits at only around 30 GW — meaning nearly 80% of module assembly still depends on imported cells. With ALMM List-II for solar PV cells now requiring domestically made cells for most project categories, that five-to-six-times gap between module and cell capacity has turned into an active procurement constraint, with some manufacturers reporting cell wait times stretching to eight months and production cuts across a third of small and mid-sized panel makers.

The Scale of the Gap

Nameplate solar cell manufacturing capacity in India stands at roughly 30 GW, forming only about 20 percent of module manufacturing capacity — for the remaining 80 percent, module manufacturing has had to depend on imported cells, primarily from China. Module manufacturing capacity has outpaced cell manufacturing capacity by more than five times, creating high demand for new cell production.

The imbalance gets sharper when you look at specific technologies. Domestic solar cell capacity, at about 31 GW, is far below module manufacturing capacity of around 193 GW — and the mismatch is sharper in TOPCon, where approved module capacity is nearly 172 GW but domestic TOPCon cell capacity is only around 10 GW. A module manufacturer betting on N-type technology for its higher efficiency is, in practice, betting on the thinnest slice of an already-thin domestic supply.

Must read: DCR vs Non-DCR Solar Cells: Complete Guide for Indian Buyers, EPCs, and Developers (2026)

Why Value Addition Makes This Worse, Not Better

Nearly 60 percent of the solar module cost is attributable to the solar cell itself — so the component in shortest domestic supply also happens to be the one carrying the largest share of a module’s bill of materials. That combination is exactly what makes cell availability a pricing risk as much as a timeline risk: a supply-constrained input that dominates cost structure gives cell manufacturers unusual pricing leverage over standalone module assemblers.

What’s Actually Happening on the Ground

The numbers above were a forecast risk earlier in 2026. By mid-year, they had become an operational reality. India currently has around 200 GW of solar panel manufacturing capacity but only 27 GW of solar cell production capacity, with effective output estimated at just 16–18 GW — and industry sources report new rules restricting imported Chinese cells have left manufacturers waiting up to eight months for domestic supplies.

As a result, nearly one-third of India’s small and medium-sized solar panel makers have halted production, while others have significantly reduced operations. The All India Solar Module Manufacturers Association reported that nearly a third of the country’s 140 small- and medium-sized panel makers — representing 60% of manufacturing capacity — have halted output entirely, with the rest cutting operating cycles to three or four days a week.

One module maker described the practical impact bluntly: after suffering from cell unavailability for months, production was expected to shrink from 3.2 GW to about 1 GW. That’s not a rounding-error disruption — it’s a two-thirds capacity cut driven entirely by an upstream input shortage.

Why New Cell Capacity Can’t Simply Switch On

Industry voices have pushed back on the idea that new cell lines can be commissioned on short notice, noting it is genuinely difficult to start producing cells within 18 months given the complexity of the technology, the land requirements, and the sourcing of raw materials. Cell manufacturing is a fundamentally different capital and technical undertaking than module assembly — diffusion furnaces, PECVD lines, and screen printers require longer lead times, deeper process expertise, and larger upfront capital than a module assembly line, which is one reason India’s cell capacity has consistently trailed module capacity by a wide margin.

The Policy Response — And Its Limits

MNRE has offered partial relief rather than a blanket delay. The government granted net-metering and open-access solar projects an extension until December 31, 2026 to comply with the domestic-cell requirement, while maintaining a firm stance on the core policy and ruling out a blanket extension for all project categories. For a full breakdown of exactly which project categories qualify for this window, see our companion piece on ALMM List-II compliance requirements.

Manufacturers remain broadly optimistic about the medium term, with several new manufacturing facilities expected to become operational in phases through December 2026, which industry players expect will significantly strengthen domestic cell availability. But “several new facilities becoming operational” is a multi-quarter process — it does not resolve procurement risk for projects with near-term commissioning deadlines.

What This Means for Your Procurement Strategy

1. Cell-level supply is now a bigger scheduling risk than module-level supply. Traditional procurement risk assessments that focus on module lead times need to be rebuilt around cell availability specifically — ask suppliers directly about their cell source, not just their module brand.

2. Vertically integrated manufacturers carry materially lower supply risk right now. A manufacturer producing its own cells in-house isn’t exposed to the eight-month wait times being reported industry-wide for third-party cell supply. Websol Energy System Limited manufactures its own M10 Bifacial Mono-PERC cells rather than sourcing them externally — worth a specific question to ask any module supplier during vendor qualification: do they make their own cells, or are they waiting in the same queue as everyone else?

3. Lock in supply commitments earlier than you’re used to. With a sharp gap between India’s ~193 GW of module capacity and just ~31 GW of cell capacity, especially in TOPCon technology, cell capacity that exists today will get contracted quickly. Waiting until a tender is won to start cell sourcing conversations is now a material timeline risk.

4. Technology choice affects supply risk. Given the sharper TOPCon-specific gap, projects specified for TOPCon modules should budget more schedule contingency than Mono-PERC-specified projects, where domestic capacity is comparatively more mature.